Geoffrey M.D. Ling

Insider Reports History

Entity
Individual
Location
C/O Catalyst Biosciences, Inc., 611 Gateway Boulevard, Suite 710, South San Francisco, CA
Signature
/s/ Kyle Fletcher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Geoffrey M.D. Ling:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Celularity Inc Director Class A Common Stock 67.4K $277K $4.11 Dec 19, 2024 Direct
CATALYST BIOSCIENCES, INC. Director Common Stock 31.8K $14.9K $0.47 Jan 7, 2022 Direct
Celularity Inc Director Stock Option (Right to Buy) 1.33M Dec 19, 2024 Direct
CATALYST BIOSCIENCES, INC. Director Stock Option (Right to Buy) 14K Jun 9, 2021 Direct

Insider Reports Filed by Geoffrey M.D. Ling

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CELU Celularity Inc Dec 19, 2024 2 $0 4 Jan 6, 2025 Director
CELU Celularity Inc Aug 31, 2023 1 $0 4 Oct 16, 2023 Director
CELU Celularity Inc Aug 31, 2023 0 $0 3 Oct 16, 2023 Director
CBIO CATALYST BIOSCIENCES, INC. Jan 7, 2022 1 $0 4 Jan 7, 2022 Director
CBIO CATALYST BIOSCIENCES, INC. Oct 1, 2021 1 $0 4 Oct 5, 2021 Director
CBIO CATALYST BIOSCIENCES, INC. Jun 9, 2021 2 $0 4 Jul 2, 2021 Director